Letermovir

Category: Antiviral



Letermovir Overview

Letermovir (INN; trade name Prevymis) is an antiviral drug for the treatment of cytomegalovirus (CMV) infections. It has been tested in CMV infected patients with allogeneic stem cell transplants and may also be useful for other patients with a compromised immune system such as those with organ transplants or HIV infections.[1] The drug was developed by Merck & Co., Inc as investigative compound MK-8228.[2] The drug was granted fast track status by the US ...

Read more Letermovir Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Letermovir

Recent Letermovir Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Letermovir
  • Injection: 240mg/12ml, 480mg/24ml
  • Solution: 240mg/12ml (20mg/ml), 480mg/24ml (20mg/ml)
  • Tablet: 240mg, 480mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Letermovir or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 16 January 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA